Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A van Dam

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility studyP A van Dam, J Hauspy, T Vanderheyden, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 19, 2016
Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative?P A van Dam, V C N van Dam, S Altintas, et al.
Facts, Views & Vision in Obgyn|March 16, 2016
The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectivesK Papadmitriou, X B Trinh, S Altintas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Current and future role of circulating tumor cells in patients with epithelial ovarian cancerC Van Berckelaer, A J Brouwers, D J E Peeters, et al.
Journal of Clinical Pathology|October 1, 1989
Prognostic value of prostaglandin F2 alpha concentrations in breast carcinomaP A van Dam, I B Vergote, G M Laekeman, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Prostacyclin/thromboxane ratio in human breast cancerI B Vergote, P A van Dam, G M Laekeman, et al.
Gynecologic Oncology|September 1, 1991
Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tractP A van Dam, D G Lowe, J V Watson, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Benchmarking and audit of breast units improves quality of careP A van Dam, L Verkinderen, J Hauspy, et al.
Radiology|February 1, 1988
Palpable solid breast masses: retrospective single- and multimodality evaluation of 201 lesionsP A van Dam, M L Van Goethem, E Kersschot, et al.
ESMO Open|March 19, 2022
Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patientsP A van Dam, Y Debie, L Teuwen, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 27, 2003
Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility studyP A van Dam, J Hauspy, T Vanderheyden, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 19, 2016
Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative?P A van Dam, V C N van Dam, S Altintas, et al.
Facts, Views & Vision in Obgyn|March 16, 2016
The socio-economical impact of intravenous (IV) versus subcutaneous (SC) administration of trastuzumab: future prospectivesK Papadmitriou, X B Trinh, S Altintas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Current and future role of circulating tumor cells in patients with epithelial ovarian cancerC Van Berckelaer, A J Brouwers, D J E Peeters, et al.
Journal of Clinical Pathology|October 1, 1989
Prognostic value of prostaglandin F2 alpha concentrations in breast carcinomaP A van Dam, I B Vergote, G M Laekeman, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1991
Prostacyclin/thromboxane ratio in human breast cancerI B Vergote, P A van Dam, G M Laekeman, et al.
Gynecologic Oncology|September 1, 1991
Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tractP A van Dam, D G Lowe, J V Watson, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Benchmarking and audit of breast units improves quality of careP A van Dam, L Verkinderen, J Hauspy, et al.
Radiology|February 1, 1988
Palpable solid breast masses: retrospective single- and multimodality evaluation of 201 lesionsP A van Dam, M L Van Goethem, E Kersschot, et al.
ESMO Open|March 19, 2022
Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patientsP A van Dam, Y Debie, L Teuwen, et al.
Pageof 6